Pelthos Therapeutics Inc.
AMEX:PTHSBiotechnology
-$0.37 today
- Market cap
- $63.32M
- Beta
- 3.13
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$15.58
Volume 0.01M
Average 0.04M
PTHS Total Current Assets
All assets expected to be converted to cash or used up within one year.
Pelthos Therapeutics Inc.AMEX: PTHS
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 7482.5% from a year ago
Total current assets stood at $69.09M at the end of Q1 FY2026, up 7482.5% from a year earlier and up 31.1% from the prior quarter. Over 3 fiscal years it compounded at +885.4% a year.
Context
- Total current assets amounted to 47.5% of total assets at the end of Q1 FY2026, down 52.5 pp from a year earlier.
- Total current assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +7482.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 52.7M USD
- Year-over-year change
- +3749.1%
- 3-year CAGR
- +885.4%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 52.7M | +3749.1% |
| FY2024 | 2024-12-31 | 1.37M | +1320.4% |
| FY2023 | 2023-12-31 | 96.39K | +75.0% |
| FY2022 | 2022-12-31 | 55.07K | — |
Total Current Assets vs competitors
How PTHS compares with its peers on the latest reported figures
- PTHS's Mar 2026 total current assets of $69.09M is the 2nd highest of the 4 companies compared; the peer median is $27.91M.
- Its year-over-year change of +7482.5% is the highest of 4, against a peer median of +165.7%.
- Total current assets amounts to 47.5% of total assets for PTHS, versus a peer median of 74.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $1.74B | +6606.3% | +221.8% | 74.9% | |
| Mar 2026 | $69.09M | +7482.5% | +885.4% | 47.5% | |
| Mar 2026 | $27.91M | +165.7% | +15.1% | 90.4% | |
| Mar 2026 | $3.41M | +125.0% | -2.3% | 31.4% | |
| Peer median (excluding PTHS) | $27.91M | +165.7% | +15.1% | 74.9% | |
Competitors are the stored peer set for PTHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Pelthos Therapeutics Inc.
AMEX:PTHS
Intrinsic Alpha fair value
Locked
Current Price
$16.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.